Sally L. Buck
Alcon
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Sally L. Buck.
Contact Lens and Anterior Eye | 1998
Sally L. Buck; Ruth A. Rosenthal; Robert L. Abshire
The amoebicidal activity of a contact lens multipurpose disinfecting solution (MPDS) containing polyquaternium-1 and myristamidopropyl dimethylamine was compared to a disinfection/neutralisation peroxide system against Acanthamoeba castellanii and Acanthamoeba polyphaga trophozoites and cysts. A quantitative microtitre method was used to evaluate the solutions. The MPDS showed similar amoebicidal activity to the disinfection/neutralisation peroxide system against the trophozoites of both species and equal or more rapid activity against the cysts of both species.
Journal of Eukaryotic Microbiology | 2003
Frederick L. Schuster; Sally L. Buck; Ruth A. Rosenthal; Barry A. Schlech
Amebic keratitis (AK) is a sight-threatening infection caused by the free-living ameba, Acanthamoeba. It can result from corneal trauma but by far the greatest number of cases of AK has been associated with the use of extended-wear soft contact lenses [S]. To date, approximately 3,000 cases have been reported or described in the literature. Among contact lens wearers, a source of infection is the use of ophthalmic saline solutions prepared from non-sterile tap or distilled waters, in which amebae are present either as trophozoites or cysts. Another source is bacterial films that develop in the lens case as a result of poor hygiene, which can provide a food supply for amebae and an opportunity for their attachment to the stored contact lens and, ultimately, the corneal surface. Chlorhexidene gluconate, polyhexamethylene biguanide, and propamidine isethionate used in therapy for AK have greatly improved chances of recovery following infection [7]. However, there are strains of Acanthamoeba isolated from keratitis victims that have shown resistance to these drugs, and there is interest in finding new drugs for controlling infection. We have tested myristamidopropyl dimethylamine (MAPD), present as AldoxB (at a concentration of 5 pg/ml) in Opti-Free Express Disinfecting Solution for contact lens care [51 for its potential as a drug in treatment of Acanthamoeba keratitis. MAPD is an amidoarnine compound that shows activity against Acanthamoeba as well as a variety of other causal agents of microbial keratitis [1,31.
Eye & Contact Lens-science and Clinical Practice | 2005
Sally L. Buck; Ruth A. Rosenthal; Barry A. Schlech
Journal of Ocular Pharmacology and Therapeutics | 2006
Ruth A. Rosenthal; Sally L. Buck; Cindy L. Henry; Barry A. Schlech
Archive | 2001
Ronald L. Schlitzer; Nissanke L. Dassanayake; Ruth A. Rosenthal; Sally L. Buck
Investigative Ophthalmology & Visual Science | 2004
Barry A. Schlech; S. Sutton; R.A. Rosenthal; R. Berry; Sally L. Buck
Optometry - Journal of The American Optometric Association | 2008
Roya Borazjani; Roya Nicole Borazjani; Sally L. Buck; Cindy McAnally; Ronald L. Smith; Barry A. Schlech
Investigative Ophthalmology & Visual Science | 2008
Sally L. Buck; R. Smith; Barry A. Schlech
Optometry - Journal of The American Optometric Association | 2006
Ruth A. Rosenthal; Cindy L. Henry; Barry A. Schlech; Sally L. Buck
Investigative Ophthalmology & Visual Science | 2006
R.A. Rosenthal; Barry A. Schlech; Sally L. Buck